Table 4.
Viral DNA helicases. AAV, Adeno‐associated virus; ACNP, Autographa californica nuclear polyhedrosis; BPV, bovine papilloma virus; HSV, herpes simplex virus; MVM NS1, minute virus of mice–nonstructural protein; nd, not determined; OBP, origin binding protein; SV40 T‐antigen, Simian virus 40 large T antigen; SARS‐CoV, severe acute respiratory syndrome coronavirus (Coronoviridae helicase).
S. No. | Name of helicase | Mol. mass (kDa) | Nucleotide cofactors | Polarity | Remarks |
---|---|---|---|---|---|
1 | SV40 T‐antigen a | 94 | ATP > dATP > dTTP = UTP | 3′−5′ | Interacts with DNA pol. α; essential for DNA replication; contains both DNA and RNA helicase activities. |
2. | Polyoma T‐antigen b | 100 | ATP = dATP > CTP = UTP | 3′−5′ | Contains Polyoma ori binding and unwinding activities. |
3. | HSV‐1. UL5/UL8/UL52 Complex c | 120 97 70 | ATP > GTP > CTP = UTP | 5′−3′ | UL5 and UL52 required for helicase‐primase activity. |
4. | HSV‐1, UL9 protein d | 68 | ATP = dATP > CTP > dCTP | 3′−5′ | OBP involved during the initiation of HSV replication. |
5. | BPV‐1, E1 protein e | 68 | ATP, dATP, CTP, dCTP, UTP, dTTP, GTP, dGTP | 3′−5′ | OBP, which is stimulated by E2 protein of BPV‐1. |
6. | AAV, Rep68, Rep78 f | 68 71 | ATP > CTP > dATP > GTP > UTP | 3′−5′ | Contains site‐and strand‐specific endonuclease activity. |
7. | AAV‐Rep52 g | 52 | ATP, dATP, CTP, dCTP, UTP, dTTP, GTP, dGTP | 3′−5′ | Lysine to histidine substitution within motif I was deficient for both DNA helicase and ATPase activities. |
8. | AAV‐Rep40 h | 40 | ATP | 3′−5′ | Lysine to histidine mutation in the purine nucleotide‐binding site results in a protein that inhibits helicase activity. |
9. | MVM NS‐1 i | 83 | ATP > dATP | nd | Appears to have site‐specific endonuclease activity. |
10. | ACNP virus P143 j | 143 | ATP | nd | Stimulated by LEF3/SSB; essential for virus DNA replication. |
11. | Vaccinia virus A18R k | 57.5 | ATP | 3′−5′ | It is a DExH box protein and is involved in transcription. |
12 | SARS‐CoV helicase l | 70 | ATP, dATP, CTP > all others | 5′−3′ | Attractive target for anti‐SARS therapy. |